| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |